Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription 15.07.2024 1 Ann Intern Med 2 BMC Gastroenterol 1 Dig Dis Sci 1 Gut 4 J Gastroenterol Hepatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
   Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
   Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

2. SUN J, Yan C, Wen J, Wang F, et al
   Association between different obesity patterns and the risk of NAFLD detected by transient elastography: a cross-sectional study.
   BMC Gastroenterol. 2024;24:221.
   PubMed         Abstract available
   
   
3. ALKHOURI N, Almomani A, Le P, Payne JY, et al
   The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: analysis of the NHANES 2017-2018 cycle.
   BMC Gastroenterol. 2024;24:218.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

4. EDELSON JC, Rockey DC
   Safety of Endoscopy in Cirrhosis.
   Dig Dis Sci. 2024 Jul 8. doi: 10.1007/s10620-024-08539.
   PubMed         Abstract available
   
   

   
   Gut

5. MANTOVANI A, Tilg H, Targher G
   FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials.
   Gut. 2023 Sep 27:gutjnl-2023-331115. doi: 10.1136/gutjnl-2023-331115.
   PubMed        
   
   

   
   J Gastroenterol Hepatol

6. MALANDRIS K, Papandreou S, Vasilakou D, Kakotrichi P, et al
   Efficacy of pharmacologic interventions on magnetic resonance imaging biomarkers in patients with nonalcoholic fatty liver disease: systematic review and network meta-analysis.
   J Gastroenterol Hepatol. 2024;39:1219-1229.
   PubMed         Abstract available
   
   
7. LIU Y, Hu Y, Li B, Su R, et al
   Innate lymphoid cell subsets in the pathogenesis of primary biliary cholangitis.
   J Gastroenterol Hepatol. 2024 Apr 12. doi: 10.1111/jgh.16547.
   PubMed         Abstract available
   
   
8. WANG X, Liu H, Wang Y, Wang P, et al
   Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway.
   J Gastroenterol Hepatol. 2024 Mar 24. doi: 10.1111/jgh.16538.
   PubMed         Abstract available
   
   
9. WANG J, Zhang Y, Ma Y, Zhao S, et al
   TET1 inhibits liver fibrosis by blocking hepatic stellate cell activation.
   J Gastroenterol Hepatol. 2024 Feb 18. doi: 10.1111/jgh.16443.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.